Synthesis and PTP1B inhibition of 1,2-naphthoquinone derivatives as potent anti-diabetic agents

被引：67

作者：

Ahn, JH ^{[1
]}

Cho, SY ^{[1
]}

Ha, JD ^{[1
]}

Chu, SY ^{[1
]}

Jung, SH ^{[1
]}

Jung, YS ^{[1
]}

Baek, JY ^{[1
]}

Choi, IK ^{[1
]}

Shin, EY ^{[1
]}

Kang, SK ^{[1
]}

Kim, SS ^{[1
]}

Cheon, HG ^{[1
]}

Yang, SD ^{[1
]}

Choi, JK ^{[1
]}

机构：

[1] Korea Res Inst Chem Technol, Div Med Sci, Taejon 305600, South Korea

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 15期

关键词：

D O I：

10.1016/S0960-894X(02)00331-1

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new series of 1,2-naphthoquinone derivatives was synthesized by various synthetic methods and evaluated for their ability to inhibit protein tyrosine phosphatase 1B (PTP1B). 1, 2-Naphthoquinone derivatives with substituent at R-4 position showed submicromolar inhibitory activity, and compound 24 demonstrated 10- to 60-fold selectivity against the tested phosphatases. Also, several 4-aryl-1,2-naphthoquinone derivatives with substituents at R-3, R-6, R-7, or/and R-8 showed submicromolar inhibitory activity and good plasma stability. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：1941 / 1946

页数：6

共 42 条

[1] 2-(Oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases [J].

Andersen, HS ;

Iversen, LF ;

Jeppesen, CB ;

Branner, S ;

Norris, K ;

Rasmussen, HB ;

Moller, KB ;

Moller, NPH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) :7101-7108

[2] PROTEIN-TYROSINE PHOSPHATASES TAKE-OFF [J].

BARFORD, D ;

JIA, ZC ;

TONKS, NK .

NATURE STRUCTURAL BIOLOGY, 1995, 2 (12) :1043-1053

[3] OXIDATION OF PHENOLS, PYROCATECHOLS, AND HYDROQUINONES TO ORTHO-QUINONES USING BENZENESELENINIC ANHYDRIDE [J].

BARTON, DHR ;

BREWSTER, AG ;

LEY, SV ;

READ, CM ;

ROSENFELD, MN .

JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1981, (05) :1473-1476

[4] Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin actions [J].

Bleasdale, JE ;

Ogg, D ;

Palazuk, BJ ;

Jacob, CS ;

Swanson, ML ;

Wang, XY ;

Thompson, DP ;

Conradi, RA ;

Mathews, WR ;

Laborde, AL ;

Stuchly, CW ;

Heijbel, A ;

Bergdahl, K ;

Bannow, CA ;

Smith, CW ;

Svensson, C ;

Liljebris, C ;

Schostarez, HJ ;

May, PD ;

Stevens, FC ;

Larsen, SD .

BIOCHEMISTRY, 2001, 40 (19) :5642-5654

[5]

BUTERA JA, 2001, Patent No. 6214877

[6] A FACILE ROUTE TO PERYLENEQUINONE [J].

CHAO, C ;

ZHANG, P .

TETRAHEDRON LETTERS, 1988, 29 (02) :225-226

[7] Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene [J].

Elchebly, M ;

Payette, P ;

Michaliszyn, E ;

Cromlish, W ;

Collins, S ;

Loy, AL ;

Normandin, D ;

Cheng, A ;

Himms-Hagen, J ;

Chan, CC ;

Ramachandran, C ;

Gresser, MJ ;

Tremblay, ML ;

Kennedy, BP .

SCIENCE, 1999, 283 (5407) :1544-1548

[8]

Evans J L, 1999, Expert Opin Investig Drugs, V8, P139, DOI 10.1517/13543784.8.2.139

[9] The reaction of hydrazoic acid with the naphthoquinones [J].

Fieser, LF ;

Hartwell, JL .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1935, 57 :1482-1484

[10] Synthesis and characterization of a potent and selective protein tyrosine phosphatase inhibitor, 2-[(4-methylthiopyridin-2-yl)methylsufinyl]benzimidazole [J].

Hamaguchi, T ;

Takahashi, A ;

Kagamizono, T ;

Manaka, A ;

Sato, M ;

Osada, H .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (23) :2657-2660

← 1 2 3 4 5 →